We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Ameresco
AMRC
$1.36B
| $1.19M | ﹤0.01% |
24,552
-3,409
| -12% | -$188K |
|
|
NVEE
2127
DELISTED
NV5 Global
NVEE
| $1.19M | ﹤0.01% |
49,284
-3,880
| -7% | -$92.5K |
|
|
GTHX
2128
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.19M | ﹤0.01% |
49,478
-4,357
| -8% | -$101K |
|
|
ECOM
2129
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $1.19M | ﹤0.01% |
50,454
-2,060
| -4% | -$45.5K |
|
2130
Nicolet Bankshares
NIC
$3.62B
| $1.19M | ﹤0.01% |
14,206
-978
| -6% | -$74.5K |
|
2131
Beazer Homes USA
BZH
$907M
| $1.18M | ﹤0.01% |
56,468
-2,502
| -4% | -$46.1K |
|
2132
Parsons
PSN
$5.08B
| $1.18M | ﹤0.01% |
29,060
-4,525
| -13% | -$171K |
|
|
CAMP
2133
DELISTED
CalAmp Corp.
CAMP
| $1.17M | ﹤0.01% |
4,685
+131
| +3% | +$33.3K |
|
|
RDUS
2134
DELISTED
Radius Health, Inc.
RDUS
| $1.17M | ﹤0.01% |
56,020
-7,518
| -12% | -$158K |
|
2135
Camden National
CAC
$976M
| $1.17M | ﹤0.01% |
24,407
-1,290
| -5% | -$54K |
|
|
TVRD
2136
Tvardi Therapeutics
TVRD
$23.4M
| $1.16M | ﹤0.01% |
1,488
-96
| -6% | -$65.7K |
|
|
BWIN
2137
Baldwin Insurance Group
BWIN
$2.86B
| $1.16M | ﹤0.01% |
42,602
+16
| +0% | +$435 |
|
2138
Berkshire Hathaway Class A
BRK.A
$1.12T
| $1.16M | ﹤0.01% |
3
+2
| +200% | +$733K |
|
2139
Krystal Biotech
KRYS
$9.66B
| $1.16M | ﹤0.01% |
14,999
-111
| -0.7% | -$8.07K |
|
|
AIV
2140
Aimco
AIV
$383M
| $1.15M | ﹤0.01% |
187,936
-23,205
| -11% | -$118K |
|
2141
CNA Financial
CNA
$14.1B
| $1.15M | ﹤0.01% |
25,713
+310
| +1% | +$13.2K |
|
2142
Community Trust Bancorp
CTBI
$1.41B
| $1.13M | ﹤0.01% |
25,709
-1,370
| -5% | -$56.3K |
|
|
FRG
2143
DELISTED
Franchise Group, Inc.
FRG
| $1.13M | ﹤0.01% |
31,149
-990
| -3% | -$35.1K |
|
2144
Alector
ALEC
$199M
| $1.12M | ﹤0.01% |
55,831
-4,001
| -7% | -$71.7K |
|
2145
Unitil
UTL
$980M
| $1.12M | ﹤0.01% |
24,563
-1,176
| -5% | -$51.4K |
|
|
NEX
2146
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $1.12M | ﹤0.01% |
301,677
-12,777
| -4% | -$51.7K |
|
2147
Seneca Foods Class A
SENEA
$1.21B
| $1.12M | ﹤0.01% |
23,781
+702
| +3% | +$33.6K |
|
2148
SiTime
SITM
$21.8B
| $1.11M | ﹤0.01% |
11,272
+1,510
| +15% | +$177K |
|
2149
QCR Holdings
QCRH
$1.7B
| $1.1M | ﹤0.01% |
23,337
-1,340
| -5% | -$57.4K |
|
2150
Regis Corp
RGS
$70.2M
| $1.1M | ﹤0.01% |
4,382
+13
| +0.3% | +$2.84K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.